Drug compliance among hypertensive patients; an area based study

European Journal of General Medicine

Volumn 6, Issue 1, 2009, Pages 6-10

  Al Mehza, Amal M ^a   Al Muhailije, Fatma A ^a   Khalfan, Maryam M ^a   Al Yahya, Ali A ^a  

^a Hadiya Clinic   (Kuwait)

Author keywords

Blood pressure control; Compliance; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; KUWAIT; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PILL; POLYPHARMACY; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

EID: 64649084495     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: 10.29333/ejgm/82628     Document Type: Article

References (43)

1. Chobanian AV, Bakris GL, Black HR, et.al, and the National High Blood Pressure Education Program Coordinating Committee, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA 2003; 289: 3560-72
2. 1990 World Health Organization- International S ociety of Hypertension Guideline for the Management of Hypertension. Guideline Subcommittee. J Hypertens 1999;17:151-83
3. Primary Health Care Clinical Practice Guideline Series: Hypertension, Kuwait. Ministry of Health, central department of Primary Health Care 2001;2
4. Arauz Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care 2002;25:134-47
5. Joint National Committee. Fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-83
6. Neaton Jo, Grimm J, Richard H, et. al. Treatment of mild hypertension study. Research group final report. JAMA 1993; 270: 713-24
7. Houston MC. Hypertension strategies for therapeutic intervention and prevention of end- organ damage. Prim Care 1991;18:713-53
8. Glasser SP. Hypertension syndrome and cardiovascular events; high blood pressure is only one risk factor. Post Grad Med 2001; 110:29-36
9. Palmieri V, Wachtell K, Gredtsk, et.al. Left ventricular function and hemodynamics of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the left study. Am Heart J 2001;141:784-91
10. Pocok SJ, McCormack V, Gueyffier F, et.al. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patients data from randomized controlled trials. BMJ 2001;323:75-81
11. The 2001 Canadian Hypertension Recommendation-what is new and what is old but still important. Can J Cardiol 2002; 18(6). WWW.Pulsus. Com / CARDIOL/ 18-60/ camp-ed.htm
12. Rosei EA. Assessment of pre clinical target organ damage in hypertension: Left Ventricular hypertrophy. European society of Hypertension Scientific Newsletter: Up date on Hypertension Management 2001; 2:N0.10
13. Mac Machons, Rodgers A. The effect of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clinic Exp Hypertens 1993;15:967-78
14. El Reshid K, Al-Owish R, Diab A. Hypertension in Kuwait: the Past, Present and Future. Suadi J Kidney Dis Transplant 1999;10(3) 357-64
15. Al-Yahya AA, Al-Duwaisan HS, Al-Mehza AM. Improving the Diagnosis of Hypertension and Assessment of Vascular Risk Factors through A Clinic Audit in Kuwait Family Practice. KMJ 2003;35(2)
16. Lever AF, Ramsay LE. Treatment of hypertension in elderly. J Hypertens 1 995;1 3: 571-9
17. Kaplan NM. Cardiovascular risk reduction: the role of antihypertensive treatment. Am J Med 1991;90(suppl 1A):19-20
18. Collins R, Peto R, MacMahon S, et.al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: over view of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38
19. Neaton JD, Grimm RH, Prineas RJ, et.al. Treatment of mild hypertension study: final results. J Am Med Soc 1993;270:713-24
20. Joshi PP, Salker RG, Heller RF. Determinants of poor blood pressure control in urban hypertensives of central India. J Hum Hyperten 1996;10:299-303
21. Winick off RN, Murphy PK. The persistent problem of poor blood pressure control. Arch Intern Med 1987;147:1393-6
22. Buck CW, Donner AP. Blood pressure control in hypertensives: a model for the study of life events. J Chr Dis 1984;4:247-53
23. Shea S, Misra D, Ehrlich MH, et.al. Predisposing factors for severe, uncontrolled hypertension in an inner- city minority population. N Engl J Med 1992;327:776-81
24. Leenen F HH. Intermittent blood pressure control: Potential consequences for out com. Can J Cardiol 1999;15(supplc):13c-18c
25. Bittar N. Maintaining long- term control of blood pressure: the role of improved compliance. Clin Cardiol 1995;18:312-6
26. Jones J k. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. Br Med J 1995;311:293-5
27. Mc Combs JS, Nichol MB, New man CM, et. al. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Car(US) 1994;32(3):214-26
28. Psaty BM. Temporal patterns of antihypertensive medication use among elderly patients. JAMA 1993;270:1837-41
29. Shea S, Misra D, Ehrilch MH, et.al. Correlates of Non adherence to Hypertension Treatment in an lnner-City Minority population. Am J Public Health 1992;82(12):1607-12
30. Setaro JF, Black Hr. Refractory hypertension. N Engl Med 1992;327:543-7
31. Wagner EH, James SA, Beresford SAA, et.al. The Edgecomb County High Blood Pressure Program: I. Correlates of uncontrolled hypertension at base line. Am J Public Health 1984;74:237-42
32. Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive population. Am Health J 1991;121:664-9
33. Sharkness CM, Snow DA. The patient's view of hypertension and compliance. Am J Prev Med 1992;8:141-6
34. Richardson MA, Simons-Morton B, Annegers JF. Effect of perceived barriers on compliance with antihypertensive medications. Health Educ Q 1993;20:489-503
35. Elzubier AG, Husain AA, Suleiman IA, et.al. Drug compliance among hypertensive patients in Kassala, Eastern Sudan. EMHJ 2000; 6(1): 100-5
36. Khalil SA, Elzubier AG. Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. Journal of Hypertension 1997; 15(5): 561-5
37. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J 1995;130:572-9
38. Klein LE. Compliance and Blood Pressure Control. Antihypertensive drug effects Suppl ii Hypertension 1988;11(3):61-4
39. Klein LE, German PS, McPhee ST, et al. Aging and its relationship to health knowledge and medication compliance. Gerontologist 1982; 22:384-7
40. Balazovjech I, Hnilica P Jr. Compliance with antihypertensive treatment in consultation rooms for hypertensive patients. J Hum Hypertens 1993;7:581-3
41. Grueninger UJ. Arterial hypertension: Lessons from patient education. Patient Educ couns 1995;26:37-55
42. Mc Alister FA, Lewanczuk RZ, Teok K. Resistant hypertension: An Overview. Can J Cardiol 1996;12(9):822-8
43. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Inten Med 1991;151:1786-92